Eagle’s Eye View: The AHA’s PREVENT Equations, Implantable Hemodynamic Monitors and the NOTION Trial
In this week’s View, Dr. Eagle discusses the development and validation of the American Heart Association’s PREVENT risk assessment tool. He then explores implantable hemodynamic monitors and their role in improving survival in patients with heart failure and reduced ejection fraction. Finally, Dr. Eagle talks about the 10-year outcomes of the NOTION trial regarding transcatheter or surgical aortic valve implantation.
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Cardiovascular Care Team, Heart Failure and Cardiomyopathies, Prevention, Acute Heart Failure, Acute Coronary Syndromes, Noninvasive Imaging, Vascular Medicine
Keywords: Atherosclerosis, Primary Prevention, Risk Assessment, Heart Failure, Heart Failure, Reduced Ejection Fraction, Hemodynamic Monitoring, EaglesEyeView
